DavidRDobiesMDFACC FESC

Cardiology • Hot Springs, AR

Adult Congenital Heart Disease, Interventional Cardiology

Interventional Cardiologist

Join to view full profile

Dr. Dobies is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Dobies' full profile

Already have an account?

Office
130 Medical Park Pl
Hot Springs, AR 71901
Phone+1 501-625-3400

Fax+1 501-625-3402

Education & Training

University of OxfordEssential Medical Statistics and Executive Leadership, 2018 - 2019
Allegheny Health Network Medical Education Consortium (AGH)Fellowship, Interventional Cardiology, 1999 - 2000
Corewell Health East Beaumont (Royal Oak)Fellowship, Cardiovascular Disease, 1996 - 1999
Indiana University School of MedicineResidency, Internal Medicine, 1993 - 1996
Community Health Network, Inc.Internship, Transitional Year, 1992 - 1993
Michigan State University College of Human MedicineClass of 1992

Certifications & Licensure

AR State Medical License 2021 - 2025
MI State Medical License 1996 - 2024
PA State Medical License 1999 - 2000
IN State Medical License 1993 - 1997
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease
National Board of Physicians and Surgeons Cardiovascular Disease
National Board of Physicians and Surgeons Internal Medicine
National Board of Physicians and Surgeons Interventional Cardiology

Awards, Honors, & Recognition

Circulation Circulation: Cardiovascular Interventions Editors' Picks: A Selection of the Most Important Articles Published. Circulation 2011;124:161–9. doi:10.1161/circulationaha.111.049197 Lasala JM, Cox DA, Dob, 2011
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Fellow (FACC) American College of Cardiology

Clinical Trials

IMPROVE-IT: Examining Outcomes in Subjects With Acute Coronary Syndrome: Vytorin (Ezetimibe/Simvastatin) vs Simvastatin (P04103) Start of enrollment: 2005 Oct 17
Completed
Phase 3
TAXUS ATLAS: TAXUS Liberté™-SR Stent for the Treatment of de Novo Coronary Artery Lesions Start of enrollment: 2004 Aug 01
Completed
Phase 3
Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Particpants With Acute Coronary Syndrome (TRA•CER) (Study P04736) Start of enrollment: 2007 Dec 01
Terminated
Phase 3
Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE) Start of enrollment: 2007 Sep 01
Completed
Phase 2
TAXUS ARRIVE: TAXUS Peri-Approval Registry: A Multi-Center Safety Surveillance Program Start of enrollment: 2004 Feb 01
Completed
Phase 4
CRESTOR Athero Imaging Head to Head IVUS Study Start of enrollment: 2008 Jan 01
Completed
Phase 3
A Prospective Evaluation in a Randomized Trial of TAXUS in the Treatment of De Novo Coronary Artey Lesions
Unknown status
Phase 1
A Phase 2 Safety and Efficacy Study of PRT060128, a Novel Intravenous and Oral P2Y12 Inhibitor, in Non-Urgent PCI Start of enrollment: 2008 Dec 01
Completed
Phase 2
AngelMed for Early Recognition and Treatment of STEMI Start of enrollment: 2008 Dec 01
Completed
Phase 3
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions Start of enrollment: 2009 Jan 01
Completed
Phase 3
Phase III Acute Coronary Syndrome Start of enrollment: 2009 Mar 01
Terminated
Phase 3
TAXUS Libertē Post Approval Study Start of enrollment: 2009 Dec 01
Completed
Treatment With Adenosine Diphosphate (ADP) Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome Start of enrollment: 2010 Mar 01
Completed
Prasugrel Versus Clopidogrel in Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI) Start of enrollment: 2009 Aug 01
Unknown status
EXCEL Clinical Trial Start of enrollment: 2010 Sep 29
Completed
Not Applicable
Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin Start of enrollment: 2010 Oct 01
Completed
Phase 3
Prospective, Single Blind, Rand Controlled Study to Evaluate the Safety & Effectness of Tryton Side Branch Stent Used With DES Treatmt of de Novo Bifurcation Lesions in MB & SB in Native Coronaries Start of enrollment: 2010 Dec 01
Completed
Not Applicable
The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s) Start of enrollment: 2012 Nov 01
Completed
Phase 3
Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events Start of enrollment: 2013 Apr 25
Completed
Phase 3
A Study To Determine the Efficacy and Safety of REG1 Compared to Bivalirudin in Patients Undergoing PCI Start of enrollment: 2013 Sep 01
Terminated
Phase 3
Cardiovascular Inflammation Reduction Trial - Inflammation Imaging Study Start of enrollment: 2015 Dec 18
Completed
Phase 3
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency Start of enrollment: 2017 Mar 15
Completed
Phase 3
Synergy Between PCI With TAXUS and Cardiac Surgery: SYNTAX Extended Survival Start of enrollment: 2016 Dec 01
Completed
Join now to see all

Publications & Presentations

PubMed

10 citations
Percutaneous coronary intervention with second-generation paclitaxel-eluting stents versus everolimus-eluting stents in United States contemporary practice (REWARDS TL...
Ron Waksman, Magdi G.H. Ghali, Randy Goodroe, Thomas J. Ryan, Mark Turco
The American Journal of Cardiology. 2012-10-15
9 citations
Analysis of safety outcomes for radial versus femoral access for percutaneous coronary intervention from a large clinical registry.
David Dobies, Kimberly R Barber, Amanda L Cohoon
Open Heart. 2016-08-01
62 citations
Drug-Eluting Stent Thrombosis in Routine Clinical Practice: Two-Year Outcomes and Predictors From the TAXUS ARRIVE Registries
John M. Lasala, David A. Cox, David Dobies, Kenneth W. Baran, William Bachinsky
Circulation. Cardiovascular Interventions. 2009-07-22

Abstracts/Posters

The Impact of Applying both a Critical Statistical and a Critical Clinical Appraisal to the Randomized Trials that form the Cardiology Revascularization Guidelines: Im...
Dobies DR and Barber KR, Evidence Live 2018 University of Oxford, London, England, 6/18/2018
Review of cardiology guidelines recommendations on revascularization: considerations for clinical practice
Dobies DR and Barber KR, ESC Congress 2016, Rome, Italy, 8/24/2017
Registry Based Comparison of Clinical and Safety Events by Catheterization Access Routes: Radial Versus Femoral Outcomes
Dobies DR, Cohoon AL, and Barber KR, European Society of Cardiology Congress 2015, London, England, 8/27/2015
Outcomes of Femoral versus Radial Access for Cardiac Catheterization
Dobies DR, Barber KR, and Cohoon AL, Abstracts of EuroPCR & AsiaPCR/Sing Live 2013, Paris, France, 5/21/2013
Outcomes Related to Closure Methods for Cardiac Catheterizations
Dobies DR, Cohoon AL, and Barber KR, European Society of Cardiology Congress 2012, Munich, Germany, 8/25/2012
Co-chair, Expert Panel on DES Safety, “Safety and Drug-eluting Stents: Four Years Later.”
David Dobies, European Society of Cardiology (ESC), Stockholm, Sweden, 8/28/2010
Gender Differences in Cardiac Management among 30,000 Patients with Acute Coronary Syndrome from a Community Hospital Registry
Dobies DR, Barber KR, Cohoon AL, Smith S, and Bates, A., EuroPCR 2010 Scientific Program, Paris, France, 5/24/2010
Physician / Hospital Alignment through the Co-management Agreement Model
Dobies DR, Silver M, Bonnette J, Barber KR, and Cohoon AL, International Forum on Quality and Safety Health Care 2010, Nice, France, 4/20/2010
Outcomes of Direct Injection of Intra-coronary Eptifibatide During Acute Myocardial Infarctions
Dobies DR, Barber KR, Cohoon AL, Kure CD, and Bates AA, 9th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke, Baltimore, Maryland, USA, 4/30/2008
TAXUS ARRIVE Registry: 1-year outcomes
Lasalla, Cox, and Dobies, TCT 9th Symposium, Orlando, Florida, USA, 4/2004
Join now to see all

Lectures

Critical Appraisal of Cardiology Guidelines on Revascularization: Clinical Practice
International Conference on Global Heart Disease; Paris, France - 7/8/2019
Gender differences in coronary vascular outcomes with bivalirudin versus heparin during primary coronary intervention
International Academy of Cardiology; Vancouver, Canada - 7/23/2013
Outcomes of Femoral versus Radial Access for Cardiac Catheterization
EuroPCR 2013; Paris, France - 5/22/2013
Predictors of stent thrombosis in real-world use of the TAXUS Express2 Paclitaxel-eluting stent: insights from the ARRIVE registry of 2 years
EuroPRC 2007; Barcelona, Spain - 5/22/2007
The Impact of Silent Ischemia of Cardiac Enzymes and Wall Motion in Patients Undergoing Aerobic Exercise
First International Congress of Heart Disease; Washington DC, USA - 5/1999
Mechanisms for Creatine Kinase Elevation in Coronary Artery Interventions: Angiographic Correlate
American Heart Association 71st Scientific Sessions; Dallas, Texas, USA - 11/8/1998
Mechanisms for Creatine Kinase Elevation in Coronary Artery Interventions: Angiographic Correlates
American College of Cardiology, Michigan Chapter; Traverse City, Michigan - 1997
Join now to see all

Press Mentions

Dobies, Talbert Join National Park Medical Center (Movers & Shakers)August 23rd, 2021
Interventional Cardiologist Joins HS Cardiology AssociatesAugust 9th, 2021
New District Trustees Elected for AMS BoardApril 25th, 2022